Mehdi Mesri

16.9k total citations
32 papers, 2.9k citations indexed

About

Mehdi Mesri is a scholar working on Molecular Biology, Spectroscopy and Immunology and Allergy. According to data from OpenAlex, Mehdi Mesri has authored 32 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Spectroscopy and 6 papers in Immunology and Allergy. Recurrent topics in Mehdi Mesri's work include Advanced Proteomics Techniques and Applications (12 papers), Cell Adhesion Molecules Research (6 papers) and Cell death mechanisms and regulation (5 papers). Mehdi Mesri is often cited by papers focused on Advanced Proteomics Techniques and Applications (12 papers), Cell Adhesion Molecules Research (6 papers) and Cell death mechanisms and regulation (5 papers). Mehdi Mesri collaborates with scholars based in United States, Iran and United Kingdom. Mehdi Mesri's co-authors include Dario C. Altieri, Nathan R. Wall, Richard W. Kim, Jordan S. Pober, Henry Rodriguez, Christopher R. Kinsinger, Jia Li, Jia Li, Janet Plescia and Fengzhi Li and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Mehdi Mesri

30 papers receiving 2.8k citations

Peers

Mehdi Mesri
Douglas C. Hixson United States
Tsz‐Kwong Man United States
Hans Neubauer Germany
Tatjana Crnogorac‐Jurcevic United Kingdom
Marta Sänchez‐Carbayo Spain
Remond J.A. Fijneman Netherlands
Maria Pernemalm Sweden
Satoshi Nishizuka Japan
Denise C. Connolly United States
Ru Chen United States
Douglas C. Hixson United States
Mehdi Mesri
Citations per year, relative to Mehdi Mesri Mehdi Mesri (= 1×) peers Douglas C. Hixson

Countries citing papers authored by Mehdi Mesri

Since Specialization
Citations

This map shows the geographic impact of Mehdi Mesri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehdi Mesri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehdi Mesri more than expected).

Fields of papers citing papers by Mehdi Mesri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehdi Mesri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehdi Mesri. The network helps show where Mehdi Mesri may publish in the future.

Co-authorship network of co-authors of Mehdi Mesri

This figure shows the co-authorship network connecting the top 25 collaborators of Mehdi Mesri. A scholar is included among the top collaborators of Mehdi Mesri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehdi Mesri. Mehdi Mesri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mesri, Mehdi, et al.. (2022). Evaluation and comparison of vitamin A supplementation with standard therapies in the treatment of patients with COVID-19. Eastern Mediterranean Health Journal. 28(9). 673–681. 11 indexed citations
2.
3.
Wang, Jing, Zihao Ma, Steven A. Carr, et al.. (2016). Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction. Molecular & Cellular Proteomics. 16(1). 121–134. 94 indexed citations
4.
Rudnick, Paul A., Sanford P. Markey, Yuri A. Mirokhin, et al.. (2016). A Description of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Common Data Analysis Pipeline. Journal of Proteome Research. 15(3). 1023–1032. 102 indexed citations
5.
Rivers, Robert, Christopher R. Kinsinger, Emily S. Boja, et al.. (2014). Linking cancer genome to proteome: NCI's investment into proteogenomics. PROTEOMICS. 14(23-24). 2633–2636. 21 indexed citations
6.
Ellis, Matthew J., Michael A. Gillette, Steven A. Carr, et al.. (2013). Connecting Genomic Alterations to Cancer Biology with Proteomics: The NCI Clinical Proteomic Tumor Analysis Consortium. Cancer Discovery. 3(10). 1108–1112. 215 indexed citations
7.
Chapoval, Andrei I., Glennda Smithson, Mehdi Mesri, et al.. (2013). BTNL8, a butyrophilin-like molecule that costimulates the primary immune response. Molecular Immunology. 56(4). 819–828. 27 indexed citations
8.
Mesri, Mehdi, Jenny L. Heidbrink, William W. Fitzhugh, et al.. (2013). Identification and Characterization of Angiogenesis Targets through Proteomic Profiling of Endothelial Cells in Human Cancer Tissues. PLoS ONE. 8(11). e78885–e78885. 35 indexed citations
9.
Boja, Emily S., Tara Hiltke, Robert Rivers, et al.. (2010). Evolution of Clinical Proteomics and its Role in Medicine. Journal of Proteome Research. 10(1). 66–84. 45 indexed citations
10.
Rodriguez, Henry, Robert Rivers, Christopher R. Kinsinger, et al.. (2010). Reconstructing the pipeline by introducing multiplexed multiple reaction monitoring mass spectrometry for cancer biomarker verification: An NCI‐CPTC initiative perspective. PROTEOMICS - CLINICAL APPLICATIONS. 4(12). 904–914. 32 indexed citations
11.
Nicol, Gordon R., Mark Han, Jun Kim, et al.. (2008). Use of an Immunoaffinity-Mass Spectrometry-based Approach for the Quantification of Protein Biomarkers from Serum Samples of Lung Cancer Patients. Molecular & Cellular Proteomics. 7(10). 1974–1982. 92 indexed citations
12.
Mostafazadeh, Babak, et al.. (2008). Gastrointestinal and urinary tract bleeding in methanol toxicity. BMJ Case Reports. 2008. bcr0820080619–bcr0820080619. 1 indexed citations
13.
Mesri, Mehdi, Glennda Smithson, Andrei I. Chapoval, et al.. (2006). Inhibition of in vitro and in vivo T cell responses by recombinant human Tim-1 extracellular domain proteins. International Immunology. 18(3). 473–484. 20 indexed citations
14.
Mahboubi, Keyvan, Fengzhi Li, Janet Plescia, et al.. (2001). Interleukin-11 Up-Regulates Survivin Expression in Endothelial Cells through a Signal Transducer and Activator of Transcription-3 Pathway. Laboratory Investigation. 81(3). 327–334. 99 indexed citations
15.
Mesri, Mehdi, Manuel Morales‐Ruiz, Elizabeth J. Ackermann, et al.. (2001). Suppression of Vascular Endothelial Growth Factor-Mediated Endothelial Cell Protection by Survivin Targeting. American Journal Of Pathology. 158(5). 1757–1765. 160 indexed citations
16.
O’Connor, Daniel, Jeffrey S. Schechner, Colette Adida, et al.. (2000). Control of Apoptosis during Angiogenesis by Survivin Expression in Endothelial Cells. American Journal Of Pathology. 156(2). 393–398. 298 indexed citations
17.
Mesri, Mehdi & Dario C. Altieri. (1999). Leukocyte Microparticles Stimulate Endothelial Cell Cytokine Release and Tissue Factor Induction in a JNK1 Signaling Pathway. Journal of Biological Chemistry. 274(33). 23111–23118. 274 indexed citations
18.
Mesri, Mehdi, Janet Plescia, & Dario C. Altieri. (1998). Dual Regulation of Ligand Binding by CD11b I Domain. Journal of Biological Chemistry. 273(2). 744–748. 28 indexed citations
19.
Mesri, Mehdi & Dario C. Altieri. (1998). Endothelial Cell Activation by Leukocyte Microparticles. The Journal of Immunology. 161(8). 4382–4387. 304 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Douglas C. Hixson Breakdown of academic impact, for papers by Tsz‐Kwong Man Breakdown of academic impact, for papers by Hans Neubauer Breakdown of academic impact, for papers by Tatjana Crnogorac‐Jurcevic Breakdown of academic impact, for papers by Marta Sänchez‐Carbayo Breakdown of academic impact, for papers by Remond J.A. Fijneman Breakdown of academic impact, for papers by Maria Pernemalm Breakdown of academic impact, for papers by Satoshi Nishizuka Breakdown of academic impact, for papers by Denise C. Connolly Breakdown of academic impact, for papers by Ru Chen
Rankless by CCL
2026